Ledger.Open graph →
SEC Form D · filed August 22, 2014

MyoKardia Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Kevin Starr · Boston, MADirectorTassos A. Gianakakos · South San Francisco, CAExec · DirectorCharles Homcy · South San Francisco, CADirectorKevin Starr · Boston, MADirectorMark Perry · Berkeley, CADirectorKatherine Bowdish · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗